Health Canada has concluded that Organigram Holdings’ Edison Jolts lozenge cannabis products should be classified as edibles rather than extracts.
The decision – announced in a late Friday news release – is a blow to the Canadian cannabis producer because extracts of this nature are potentially a much more lucrative product than edibles under Health Canada’s classification system for ingestibles.
ADVERTISEMENT
That’s because the distinction between a cannabis edible and extract has major implications for the marketability of those products in Canada.
Any cannabis product classified as an “extract” has 100 times more allowable THC per package than a product classified as an “edible,” making it more appealing to some consumers.
Organigram has stopped the production of Jolts in its current format and is
Read full article on Marijuana Business Daily
